March 7, 2016 Off

Pharma crusader takes India’s drug regulators to court

By Dino Mustafić

One of India’s best-known whistleblowers, who exposed dangerous practices in the generic drug industry in 2013, is taking the country’s drugs regulators to court, accusing them of failing to enforce rules on drug safety in the $15 billion (11 billion pound) industry.